HCV Veterans News
Management
& Treatment of
HCV in a
VA Setting
Congress has mandated that
Veterans be treated for Hepatitis C in all VA clinics and hospitals throughout
the United States. This means that if you are a vet and have HCV the VA
nearest you MUST treat you. If you are being refused treatment,
contact your Congressman immediately and give him the name of the VA clinic
and the name of the person who has refused to treat you. There are treatment
criteria that need to be followed for treatment, however.
Veteran
Infection Rates:
-
20% of the National infection
rate (1.8%) are veterans
-
62.7% are Vietnam War Era
Veterans
-
4.2% are WWII Veterans
-
5% are Korean War Veterans
Veteran Risk
Factors:
-
IV Drug use
= 54%
-
Transfusions =
24%
-
Tattoos
= 45%
Veteran
Infection by Race:
-
African American
= 29.4%
-
White
= 46%
-
Asian
= 4.9%
Screening
Criteria for Testing in a VA clinic:
-
Vietnam Era Veteran
-
Requested by patient
-
Blood products received prior
to 1992
-
IV/Intranasal drug use
-
Blood exposure
-
Multiple sex partners
-
hemodialysis
-
tattooing/body piercing
-
elevated liver function tests
-
intemperate alcohol use
Contraindications
to Therapy:
-
Non-compliance - i.e. not
showing up for clinic, missing appointments, not following doctors orders.
-
Life limiting non-hepatic
disease
-
Moderate to severe psychological
disease
-
Inadequite social support
-
Homeless - due to no ability
to keep meds cold.
-
Failure to use birth control
- while on combo treatment
-
Pregnancy
-
Drug and/or alcohol use -
Must be clean and sober 6 months prior to start of treatment
-
Decompensated liver disease
-
Autoimmune disorders
Patients with lesions on the
liver are NOT candidates for transplant in the VA setting. Only 10%-15%
of all HCV veterans are candidates for treatment at this time, due to alcohol/drug
use or psychological problems.
The VA requires a genotype
test done, in order to better assess the duration and type of treatment
given. The VA also screens the alpha-fetoprotein every 6 months, due to
the fact that many people have a normal AFP but have been diagnosed with
HCC.
The jet injector issue
has not been looked at by the VA because they assume there is another form
of transmission, such as drug use, tattoos, piercing, etc.
Every VA clinic should
be offering the Rebetron (combo) treatment to all vets who meet the criteria
for treatment. VA clinics should also be offering and using IntronA, Infergen,
and Roferon for those who cannot take the ribavirin in the Rebetron combo.
Monotherapy with any of these is not advised in other cases.
The VA is now doing studies
on Pegalated Interferon + Ribavirin.
Current
Recommendations:
-
Prescribe Rebetron (3 times
a week plus 1000 to 1200 mg ribavirin). Test PCR for viral load at 24 week
point. If positive, discontinue treatment. If undetected for virus at 24
weeks, continue treatment for another 24 weeks, depending on genotype of
patient.
-
All genotype 1 patients should
be screened at 24 weeks for viral load and discontinued if viral load is
present. All other genotypes should be treated for 24 weeks. Genotype 1
should be treated for 48 weeks if possible.
-
Monotherapy patients who cannot
take ribavirin should be screened for viral load at 3 months. If undetected,
treatment should continue to the 48 week point. If positive at 3 months
for viral load, stop treatment.
-
Patients who relapse after
monotherapy should be given Rebetron (combo) for 24 weeks and screened
for viral load.
-
Patients on methedone should
be treated if they have a good support system and follow all clinic requirements.
Information
Provided by:
Digestive
Disease Week 2000, San Diego, CA, May 23, 2000
Seminar
given by: Dr. Lennox Jeffers, MD, Florida VHA
VA News
Home
Page